California Toxic Tort Lawyer: Asbestos, PFAS, Glyphosate, and the Rutherford Causation Framework Under CCP § 340.8

HOME › CALIFORNIA PERSONAL INJURY › PRODUCT LIABILITY AND ABUSE › TOXIC TORT

Last updated: April 2026 — Reflects California strict product liability doctrine under Greenman v. Yuba Power Products, Inc. (1963) 59 Cal.2d 57, the California asbestos causation framework under Rutherford v. Owens-Illinois, Inc. (1997) 16 Cal.4th 953, CCP §§ 340.2 (asbestos) and 340.8 (toxic exposure discovery), Proposition 65 under Health and Safety Code § 25249.5 et seq., Civil Code § 3294, the federal preemption considerations under FIFRA (Federal Insecticide, Fungicide, and Rodenticide Act) with current Roundup Supreme Court review scheduled April 2026, and the active federal MDL consolidation framework for toxic tort product liability litigation in effect as of January 1, 2026

California toxic tort litigation encompasses the broadest category of product liability practice, covering injuries from exposure to chemicals, materials, and substances with long-latency health consequences.

The doctrinal foundation combines California's strict product liability framework under Greenman with specialized causation doctrines developed in asbestos litigation under Rutherford v. Owens-Illinois, the discovery-based statute of limitations under CCP § 340.8, and the federal regulatory frameworks that govern specific substances.

Current California toxic tort practice is dominated by asbestos (the largest and longest-running mass tort in American history), PFAS and AFFF firefighting foam litigation, glyphosate (Roundup) cancer claims, and an expanding range of chemical exposure categories, including benzene, ethylene oxide, paraquat, and others.

The practical stakes are substantial. California has been a major toxic tort venue for decades, with robust plaintiff-favorable precedent and active mass tort coordination through the Judicial Council Coordination Proceeding (JCCP) framework.

Federal MDL 2873 alone includes over 15,222 active PFAS/AFFF cases as of April 2026, with billions of dollars in settlements already paid and bellwether trials driving continued resolution. For the broader product liability and abuse framework, see our California Product Liability and Abuse guide.

The California Toxic Tort Doctrinal Foundation

California toxic tort cases typically combine several overlapping legal theories:

Strict product liability under Greenman v. Yuba Power Products, Inc. (1963) 59 Cal.2d 57 — manufacturers are strictly liable for injuries caused by defective products placed on the market. Applied to toxic substances through the three defect categories: manufacturing defect (contamination, deviation from specifications), design defect (the substance itself is unreasonably dangerous), and warning defect (failure to adequately disclose known or knowable risks).

Negligence — traditional negligence analysis applies when the defendant failed to exercise reasonable care in manufacturing, distributing, testing, labeling, or warning about the substance. Negligence claims are particularly important when specific conduct (concealment of studies, failure to test, inadequate safety protocols) supports culpability beyond strict liability analysis.

Negligent misrepresentation and fraud — when manufacturers affirmatively misrepresented safety or concealed risk data. Fraud claims support punitive damages and can extend the statute of limitations under the delayed-discovery rule.

Ultrahazardous activity — strict liability regardless of care for abnormally dangerous activities, applicable in limited circumstances to extreme toxic exposures (radiation, specialized chemical handling).

Nuisance — when toxic contamination affects property use and enjoyment. Environmental nuisance claims proceed alongside personal injury claims in groundwater contamination and air pollution cases.

Public entity claims — when government facilities contributed to exposure (military bases, contaminated Superfund sites, public water supply contamination). Subject to Government Claims Act six-month notice requirements unless specific statutory exemptions apply.

Statute of Limitations Framework

California toxic tort statutes of limitations reflect the long-latency nature of toxic exposure injuries.

CCP § 340.2 — Asbestos. Specialized statute for asbestos-related injuries. The action must be commenced within one year after the date the plaintiff first suffered disability (defined as the loss of time from work due to the asbestos-related condition, or if not employed, the loss of ability to perform regular activities), or within one year after the plaintiff first knew or should have known that the disability was caused or contributed to by exposure to asbestos. The disability-based trigger recognizes the decades-long latency between asbestos exposure and disease manifestation.

CCP § 340.8 — Toxic Exposure. General statute for civil actions for injury or illness resulting from exposure to a hazardous material or toxic substance. The action must be commenced within two years from the date of injury OR the date the plaintiff became aware (or reasonably should have become aware) of BOTH the physical cause of injury AND sufficient facts to put a reasonable person on inquiry notice that the injury was caused by a toxic substance, whichever is later. The two-part discovery rule is the central SOL tool for non-asbestos toxic tort cases.

CCP § 335.1 — Standard Personal Injury. Two years from the date of injury. Applies when the specific toxic exposure statutes do not, though § 340.8 is designed to be the primary framework for toxic substance cases.

Wrongful death: Two years from the date of death under CCP § 335.1.

Government entity claims: Six-month administrative notice under the Government Claims Act, subject to specific statutory exemptions and tolling provisions.

The discovery rule under § 340.8 is particularly important in California toxic tort practice. Cancers, neurological conditions, and autoimmune diseases frequently develop years or decades after the relevant exposure. Plaintiffs who only discovered the causal connection through medical workup, media coverage of litigation, or regulatory announcements preserve filing rights under the delayed discovery framework.

The Rutherford Framework for Asbestos and Long-Latency Toxic Exposure

California's asbestos causation framework under Rutherford v. Owens-Illinois, Inc. (1997) 16 Cal.4th 953 is the foundational California toxic tort causation doctrine, with implications extending beyond asbestos to other long-latency exposure cases.

The Rutherford holding. Given the scientific impossibility of proving which specific fiber from which specific product caused the plaintiff's disease, California plaintiffs in asbestos cases must prove:

• The plaintiff was exposed to asbestos-containing products for which the defendant is responsible

• The exposure was a substantial factor contributing to the risk of developing the plaintiff's disease

The "substantial factor in contributing to risk" standard replaced the traditional "substantial factor in causing harm" standard for asbestos cases, recognizing that specific-fiber causation is scientifically unattainable.

The standard requires expert testimony that the plaintiff's exposure to the defendant's product was "more than a negligible or theoretical exposure" and that it "contributed in a more than minimal or negligible way" to the aggregate risk of disease.

Application beyond asbestos. California courts have applied Rutherford-like analysis to other long-latency toxic tort cases where specific-molecule causation is unattainable, including benzene-induced leukemia, chemical exposure cancers, and PFAS-related diseases. The framework is particularly important in cases involving multiple defendants and multiple exposures over time.

Defendant-specific causation. Plaintiffs must still prove exposure to each defendant's specific product. Generic exposure to "asbestos" is insufficient — each defendant's liability depends on proof that the plaintiff encountered that defendant's specific asbestos-containing product. Work histories, witness testimony, product identification records, and site-specific exposure evidence support defendant-specific causation.

Apportionment among defendants. Liability is apportioned among responsible defendants based on relative contribution to risk. California's pure comparative fault framework under Li v. Yellow Cab Co. (1975) 13 Cal.3d 804 applies to apportionment. Non-settling defendants remain liable for their proportional share; settling defendants' shares reduce recovery but do not immunize non-settlers from full proportional liability.

California Asbestos Litigation

California is one of the largest asbestos litigation venues in the country, with decades of specialized practice and substantial judicial infrastructure developed around asbestos cases.

Diseases addressed: Mesothelioma (the signature asbestos-related cancer, with nearly exclusive asbestos causation), lung cancer (with asbestos as contributing cause alongside smoking), asbestosis (non-cancerous pulmonary scarring), laryngeal cancer, ovarian cancer, and cancers at other sites emerging with scientific recognition.

Defendants: Asbestos product manufacturers (many now in bankruptcy trust), construction material manufacturers, premises owners where asbestos work occurred, employers for non-workers compensation claims, ship owners and marine contractors (for maritime asbestos under the Jones Act or Longshore and Harbor Workers' Compensation Act), and talc manufacturers where talc products contained asbestos contamination.

Bankruptcy trusts. Dozens of asbestos product manufacturers have filed for bankruptcy reorganization, creating asbestos bankruptcy trusts that pay claims according to established matrices. Trust claim filing is typically part of a comprehensive asbestos case strategy, alongside civil litigation against non-bankrupt defendants.

JCCP coordination. California asbestos cases proceed through the California asbestos JCCP (Judicial Council Coordination Proceeding), with dedicated judges and specialized procedures. Los Angeles Superior Court is the most active California asbestos venue.

Talc-asbestos cases. Recent major litigation has addressed asbestos contamination in talcum powder products, with Johnson & Johnson and other manufacturers facing substantial exposure. Johnson & Johnson's bankruptcy-based resolution efforts have been unsuccessful; continued civil litigation proceeds in California and nationwide.

PFAS and AFFF Firefighting Foam Litigation

Per- and polyfluoroalkyl substances (PFAS) — often called "forever chemicals" for their environmental persistence — are the subject of massive current California and federal toxic tort litigation. California has particularly high exposure given the state's firefighting workforce, airport infrastructure, and military installations.

MDL 2873. The federal Aqueous Film-Forming Foams Products Liability Litigation consolidates over 15,222 active cases as of April 2026 in the District of South Carolina before Judge Richard M. Gergel. The MDL addresses personal injury claims from firefighters, military service members, airport personnel, and residents near contaminated water sources who developed cancer after PFAS exposure through AFFF firefighting foam.

Qualifying injuries. Kidney cancer, testicular cancer, thyroid cancer, liver cancer, thyroid disease, ulcerative colitis, and additional conditions with evolving scientific support.

Major settlements. 3M agreed to a $10.3 billion settlement for PFAS water contamination claims. DuPont, Chemours, and Corteva collectively agreed to $1.18 billion for PFAS water contamination. Tyco Fire Products (Johnson Controls) agreed to $750 million. Carrier Global/Kidde-Fenwal agreed to $730 million. BASF agreed to $316.5 million. Settlements continue to accumulate as the litigation progresses.

California state court AFFF cases. Significant California PFAS/AFFF litigation proceeds in state court alongside the federal MDL, including the consolidated proceedings involving firefighters from San Jose, Santa Clara, Gilroy, and San Francisco against PPE and AFFF manufacturers.

Science Days and bellwether process. MDL 2873 has used structured Science Days to develop causation evidence for specific disease categories, with bellwether trials advancing for kidney and testicular cancer claims, thyroid and liver cancer claims, and ulcerative colitis claims in sequence.

Filing window status. The MDL 2873 filing window has been periodically open and closed as the court manages case intake. Plaintiffs with qualifying diagnoses should consult with counsel regarding current filing eligibility.

Roundup (Glyphosate) Litigation

Monsanto's Roundup herbicide, with active ingredient glyphosate, is the subject of extensive cancer (primarily non-Hodgkin lymphoma) litigation. California has been a central venue for Roundup cases, with major verdicts including the landmark $289 million Johnson v. Monsanto verdict in 2018.

Current status as of April 2026. The U.S. Supreme Court is scheduled to hear Bayer's preemption appeal in April 2026, addressing whether Roundup personal injury claims are preempted by the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) when the EPA has not required a cancer warning.

A preemption ruling in Bayer's favor could substantially constrain or eliminate future Roundup claims; a ruling rejecting preemption would preserve the current litigation framework. The outcome will significantly affect the California Roundup, plaintiffs.

Bayer's proposed settlement. Bayer has proposed a $7.25 billion settlement to resolve current and future Roundup cases. The settlement has faced pushback from some plaintiff firms and has not received judicial approval as of this publication date.

California specific considerations. California's Proposition 65 listing of glyphosate as a chemical known to cause cancer has been central to California Roundup litigation. Bayer successfully challenged California's warning requirement on First Amendment grounds in federal court, but the underlying Prop 65 listing remains a key evidentiary reference in California state court cases.

Paraquat and Parkinson's Disease

The herbicide paraquat, primarily manufactured by Syngenta and distributed by Chevron, has been linked to Parkinson's disease in agricultural workers and others with occupational exposure. MDL 3004 in the Southern District of Illinois consolidates paraquat cases.

Affected populations: Farmworkers, commercial pesticide applicators, farm owners and operators, and others with regular paraquat exposure.

California relevance: California's extensive agricultural workforce is exposed to substantial levels of paraquat. California cases proceed in both the federal MDL and parallel state-court proceedings.

Benzene, Ethylene Oxide, and Industrial Chemical Exposure

Occupational and environmental exposure to industrial chemicals produces ongoing California toxic tort litigation.

Benzene — solvent widely used in petroleum, chemical manufacturing, and industrial applications. Linked to acute myeloid leukemia, acute lymphoblastic leukemia, non-Hodgkin lymphoma, multiple myeloma, and aplastic anemia. Workplace exposure cases and consumer product cases (sunscreens, deodorants, and other products found to contain benzene contamination) produce recurring California litigation.

Ethylene oxide — sterilization gas used in medical device processing and industrial manufacturing. Linked to breast cancer, lymphoma, and leukemia. Communities near sterilization facilities have produced substantial toxic tort litigation, with particular activity around facilities in Southern California.

Crystalline silica — workplace exposure in construction, mining, manufacturing, and particularly engineered stone fabrication (countertop manufacturing). Linked to silicosis, lung cancer, and autoimmune diseases. California has been a major venue for engineered stone silicosis cases involving young stonecutters.

Trichloroethylene (TCE) — solvent used in industrial degreasing, linked to kidney cancer, liver cancer, non-Hodgkin lymphoma, and Parkinson's disease. Groundwater contamination cases proceed in California.

Polychlorinated biphenyls (PCBs) — industrial insulators and lubricants banned in 1979 but persistent in environment. Linked to cancers and immune dysfunction.

Formaldehyde — preservative and building material component linked to nasopharyngeal cancer and leukemia.

Camp Lejeune contamination. Federal Camp Lejeune Justice Act of 2022 created a specific federal cause of action for harm from contaminated water at the Marine Corps base between 1953 and 1987. California plaintiffs with Camp Lejeune exposure have specific filing rights in the Eastern District of North Carolina through August 2024, with subsequent procedures ongoing.

Proposition 65 — The California Right-to-Know Framework

California's Proposition 65 (the Safe Drinking Water and Toxic Enforcement Act of 1986), codified at Health and Safety Code § 25249.5 et seq., requires businesses to provide clear and reasonable warnings before knowingly and intentionally exposing anyone to a chemical listed as known to the state to cause cancer or reproductive toxicity.

Prop 65's evidentiary role in toxic tort litigation:

• Prop 65 listings provide documentary evidence that a substance is "known to cause cancer" under California's administrative framework

• Prop 65 warnings (or absence of warnings) support failure-to-warn analysis

• Manufacturer responses to Prop 65 listings (reformulation, warnings, litigation challenges) produce documentary evidence of corporate knowledge

• Prop 65 enforcement actions by the Attorney General or private enforcers generate evidentiary records that can support personal injury claims

Prop 65 is not itself a personal injury cause of action — it provides administrative enforcement and civil penalty remedies separate from personal injury. But the evidentiary support Prop 65 provides for California toxic tort cases is substantial.

MDL, JCCP, and Individual Litigation

California toxic tort plaintiffs face venue and procedural options similar to the broader product liability framework.

Federal MDL consolidates related federal cases before a single judge for coordinated pretrial proceedings. Active toxic tort MDLs include PFAS/AFFF (MDL 2873), paraquat (MDL 3004), and Roundup (federal preemption review at SCOTUS). California plaintiffs routinely participate in federal toxic tort MDLs.

California JCCP consolidates related California state court cases under CCP § 404. California asbestos JCCP proceedings are the most active, with dedicated judges and streamlined procedures. Other JCCPs address specific toxic tort categories as they develop sufficient case volume.

Individual state court litigation for cases that do not qualify for consolidation, or where strategic reasons favor independent filing.

Damages in California Toxic Tort Cases

Damages follow the standard product liability framework with specific applications.

Economic damages include past and future medical expenses (often substantial in cancer and chronic disease cases), lost earnings and earning capacity, home modification costs, attendant care costs, and related economic losses. Life care planning testimony is standard in cases involving permanent disability or ongoing medical needs.

Non-economic damages include pain and suffering, emotional distress, disfigurement, and loss of enjoyment of life. Toxic tort non-economic damages are uncapped under California law — MICRA applies only to medical malpractice, not to product liability claims against chemical manufacturers.

Punitive damages under Civil Code § 3294 are frequently central in toxic tort cases. Manufacturers who knew of serious risks, concealed internal studies, continued marketing despite documented harm, or failed to warn despite regulatory developments face substantial punitive exposure.

Substantial punitive damages verdicts recur in toxic tort litigation — the Johnson v. Monsanto jury awarded $250 million in punitive damages, which was subsequently reduced on appeal; similar patterns have emerged in PFAS and asbestos cases.

Wrongful death and survival damages in fatal cases. For the wrongful death framework, see our California Product Liability Wrongful Death guide. Survival action damages under CCP § 377.30 are available for economic damages; pre-death pain and suffering is no longer recoverable in ordinary survival actions filed on or after January 1, 2026 following the SB 447 sunset — see our California Survival Action guide.

Loss of consortium. Spousal loss of consortium claims frequently proceed alongside primary toxic tort claims when the primary plaintiff survives but suffers debilitating injury.

Proving California Toxic Tort Claims

The proof framework involves several specialized evidentiary elements distinctive to toxic tort practice.

Exposure documentation. Establishing that the plaintiff was exposed to the defendant's specific product or the contamination at issue. Work history, residence history, product identification records, military service records, and occupational records support exposure. Expert testimony from industrial hygienists frequently quantifies exposure levels.

Medical causation. Expert testimony linking the exposure to the plaintiff's specific disease. Oncologists, pulmonologists, hematologists, and other medical specialists provide disease-specific causation testimony. Epidemiologists provide population-level risk evidence supporting specific causation.

General and specific causation. California requires proof that the substance is capable of causing the disease (general causation) and that it actually caused this plaintiff's disease (specific causation). The Rutherford substantial factor framework addresses specific causation in long-latency cases.

Expert testimony admissibility. California applies the Sargon v. USC framework for expert testimony under Sargon Enterprises, Inc. v. University of Southern California (2012) 55 Cal.4th 747. Federal cases apply Daubert. Expert testimony challenges are frequent preliminary litigation battlegrounds.

Manufacturer knowledge and misconduct. Internal company documents, published studies, regulatory correspondence, and witness testimony establishing what the manufacturer knew about the risks, when they knew it, and how they responded. Central to failure-to-warn claims, punitive damages, and delayed-discovery SOL arguments.

Regulatory evidence. FDA, EPA, OSHA, NIOSH, and California DTSC/OEHHA documents frequently support toxic tort cases. IARC (International Agency for Research on Cancer) classifications and National Toxicology Program reports provide authoritative scientific support. Prop 65 listings provide California-specific regulatory evidence.

What to Do If You Were Exposed to Toxic Substances in California

Document the exposure and medical diagnosis. Detailed work history, residence history, and medical records establishing the diagnosis create the factual foundation. Early documentation prevents later memory-based gaps.

Identify potential exposure sources. Products used at work, products used at home, environmental contamination, military service exposures, and occupational exposures all contribute to the exposure analysis. Specific product identification enables defendant targeting.

Preserve physical evidence where available. Product packaging, product samples, water samples (for environmental contamination), and industrial samples (for occupational exposure) provide physical evidence supporting the case.

Research applicable MDL or JCCP proceedings. For widely-recognized toxic substance categories (asbestos, PFAS/AFFF, Roundup, paraquat), existing consolidation proceedings may already address the injury category. Identification of active consolidation enables coordination with specialized counsel.

Consult with specialized toxic tort counsel early. Toxic tort litigation is highly specialized practice requiring familiarity with complex causation doctrines, MDL and JCCP practice, regulatory frameworks, and the specific scientific and medical literature for each substance category. Early consultation preserves evidence and identifies the optimal strategy.

Obtain complete medical records. Records from all treating physicians, including specialists in oncology, pulmonology, or other relevant specialties, establish the diagnosis, treatment course, and prognosis.

Secure witness statements promptly. Coworkers, supervisors, family members, and others with knowledge of the exposure support exposure documentation. Witnesses may become unavailable over time.

Preserve employment and military service records. Complete employment history, OSHA 300 logs (when available), workers compensation records, and military service records establish occupational exposure timelines.

Understand the litigation timeline. Toxic tort cases typically require 24–60 months from filing to resolution, with substantial variation by case type. Asbestos mesothelioma cases frequently receive trial preference under CCP § 36 for living plaintiffs with limited life expectancy. MDL proceedings often require several years to complete bellwether trials and develop aggregate settlements.

Frequently Asked Questions

What is a toxic tort in California? A toxic tort is a civil claim for injury caused by exposure to a harmful chemical, pharmaceutical, pesticide, pollutant, or other hazardous substance. California toxic tort cases combine strict product liability under Greenman v. Yuba Power Products, negligence, and specialized causation doctrines including the Rutherford substantial factor framework for long-latency exposure cases. The category covers asbestos, PFAS, glyphosate (Roundup), paraquat, benzene, ethylene oxide, and many other substance categories.

What is the statute of limitations for California toxic tort claims? Asbestos claims are governed by CCP § 340.2 with a one-year period from first disability or discovery of the disability's cause. Other toxic tort claims are governed by CCP § 340.8 with a two-year period running from when the plaintiff became aware (or reasonably should have become aware) of both the physical cause of injury and sufficient facts to put a reasonable person on notice that the injury was caused by a toxic substance. The discovery rule extends deadlines for plaintiffs who only discovered the causal connection after the pure occurrence-based period would have expired.

What is the Rutherford substantial factor standard? Rutherford v. Owens-Illinois, Inc. (1997) 16 Cal.4th 953 established that in asbestos cases (and by extension, other long-latency toxic tort cases), plaintiffs prove causation by showing their exposure to the defendant's product was a "substantial factor in contributing to the risk" of developing the disease, rather than requiring proof of specific-fiber or specific-molecule causation. The standard recognizes that specific-molecule causation is scientifically unattainable in long-latency cases.

Can I sue for PFAS exposure in California? Yes, if the exposure caused a qualifying medical condition. Federal MDL 2873 consolidates most federal AFFF/PFAS cases, with over 15,222 active cases as of April 2026 and billions in accumulated settlements. California state court AFFF cases proceed in parallel. Qualifying conditions include kidney cancer, testicular cancer, thyroid cancer, liver cancer, thyroid disease, and ulcerative colitis, with evolving scientific support for additional conditions.

Are punitive damages available in California toxic tort cases? Yes, frequently. Manufacturers who knew of serious risks but concealed them, continued marketing despite documented harm, suppressed internal studies, or failed to warn despite regulatory developments face substantial punitive damages exposure under Civil Code § 3294. Toxic tort punitive damages verdicts have reached hundreds of millions to billions of dollars in recent litigation, subject to constitutional limitations on the proportionality of punitive damages.

Does the MICRA cap apply to California toxic tort cases? No. MICRA applies only to medical malpractice claims against healthcare providers. Product liability claims against chemical manufacturers, pharmaceutical manufacturers, and other manufacturers of toxic substances are not subject to MICRA caps. Economic and non-economic damages in California toxic tort litigation are uncapped.

What is Proposition 65 and how does it affect my toxic tort case? Proposition 65 is California's right-to-know law requiring businesses to warn about exposures to chemicals known to cause cancer or reproductive toxicity. Prop 65 is not itself a personal injury cause of action, but Prop 65 listings, warnings (or absence of warnings), and enforcement actions provide substantial evidentiary support for California toxic tort cases. Prop 65 documentary records support failure-to-warn claims, corporate knowledge evidence, and regulatory recognition of the substance's cancer risk.

DISCLOSURE 

This page is published and maintained by 1000Attorneys.com, a California State Bar Certified Lawyer Referral and Information Service, LRIS Certificate No. 0128, accredited by the American Bar Association and established in 2005. The information on this page is for general educational purposes only and is not legal advice. 1000Attorneys.com is not a law firm and does not provide legal representation. For legal advice about your specific situation, consult a qualified California attorney licensed to practice in the jurisdiction where your claim arises.